Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Rigel Pharmaceuticals EBITDA Margin 2010-2025 | RIGL

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Rigel Pharmaceuticals (RIGL) over the last 10 years. The current EBITDA margin for Rigel Pharmaceuticals as of March 31, 2025 is .
  
Rigel Pharmaceuticals EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.20B $0.05B 22.66%
2024-12-31 $0.18B $0.03B 14.44%
2024-09-30 $0.16B $0.01B 6.96%
2024-06-30 $0.13B $-0.01B -6.11%
2024-03-31 $0.12B $-0.01B -11.57%
2023-12-31 $0.12B $-0.02B -16.24%
2023-09-30 $0.13B $-0.02B -14.39%
2023-06-30 $0.13B $-0.03B -26.19%
2023-03-31 $0.13B $-0.04B -31.78%
2022-12-31 $0.12B $-0.06B -45.83%
2022-09-30 $0.09B $-0.08B -87.64%
2022-06-30 $0.09B $-0.08B -88.76%
2022-03-31 $0.09B $-0.08B -92.94%
2021-12-31 $0.15B $-0.01B -7.38%
2021-09-30 $0.15B $-0.01B -6.12%
2021-06-30 $0.14B $0.00B -2.80%
2021-03-31 $0.13B $-0.01B -6.02%
2020-12-31 $0.11B $-0.03B -26.85%
2020-09-30 $0.11B $-0.03B -25.71%
2020-06-30 $0.11B $-0.03B -23.15%
2020-03-31 $0.10B $-0.03B -28.43%
2019-12-31 $0.06B $-0.07B -115.25%
2019-09-30 $0.08B $-0.05B -59.76%
2019-06-30 $0.07B $-0.06B -92.42%
2019-03-31 $0.06B $-0.07B -113.79%
2018-06-30 $0.00B $-0.10B -3166.67%
2017-09-30 $0.01B $-0.07B -862.50%
2017-03-31 $0.02B $-0.07B -340.00%
2016-12-31 $0.02B $-0.07B -328.57%
2016-09-30 $0.03B $-0.07B -240.74%
2016-06-30 $0.04B $-0.05B -133.33%
2016-03-31 $0.03B $-0.05B -153.13%
2015-12-31 $0.03B $-0.05B -172.41%
2012-06-30 $0.01B $-0.09B -1285.71%
2012-03-31 $0.01B $-0.09B -1740.00%
2011-09-30 $0.00B $-0.08B -1950.00%
2011-06-30 $0.07B $-0.01B -12.50%
2010-12-31 $0.12B $0.04B 29.84%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.379B $0.179B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.377B 32.78
Zoetis (ZTS) United States $74.051B 27.63
Takeda Pharmaceutical (TAK) Japan $48.270B 9.60
Daiichi Sankyo, - (DSNKY) Japan $47.264B 24.22
BeOne Medicines - (ONC) Cayman Islands $28.732B 0.00
Sandoz Group AG (SDZNY) Switzerland $22.880B 0.00
Merck (MKKGY) Germany $17.149B 12.56
Shionogi (SGIOY) Japan $14.717B 14.74
Summit Therapeutics (SMMT) United States $14.541B 0.00
United Therapeutics (UTHR) United States $12.471B 11.03
Neurocrine Biosciences (NBIX) United States $12.289B 42.09
Orion OYJ (ORINY) Finland $10.289B 27.82
IPSEN (IPSEY) France $9.940B 0.00
Corcept Therapeutics (CORT) United States $7.555B 61.41
Stevanato Group S.p.A (STVN) Italy $7.501B 45.87
Madrigal Pharmaceuticals (MDGL) United States $6.535B 0.00
Grifols, S.A (GRFS) Spain $6.154B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.760B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.980B 15.15
Soleno Therapeutics (SLNO) United States $3.989B 0.00
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Catalyst Pharmaceuticals (CPRX) United States $3.099B 10.86
Crinetics Pharmaceuticals (CRNX) United States $3.027B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.438B 13.19
NewAmsterdam Pharma (NAMS) Netherlands $2.302B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.220B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.195B 0.00
Indivior (INDV) United States $1.883B 7.99
Centessa Pharmaceuticals (CNTA) United Kingdom $1.668B 0.00
Dyne Therapeutics (DYN) United States $1.656B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.408B 0.00
Ocular Therapeutix (OCUL) United States $1.405B 0.00
Guardian Pharmacy Services (GRDN) United States $1.276B 0.00
Harrow (HROW) United States $1.160B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 21.86
Enliven Therapeutics (ELVN) United States $0.962B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.957B 0.00
Collegium Pharmaceutical (COLL) United States $0.954B 5.15
Akebia Therapeutics (AKBA) United States $0.938B 0.00
Ardelyx (ARDX) United States $0.885B 0.00
Cronos Group (CRON) Canada $0.756B 0.00
Elite Pharmaceuticals (ELTP) United States $0.726B 0.00
Xeris Biopharma Holdings (XERS) United States $0.685B 0.00
Xencor (XNCR) United States $0.678B 0.00
KalVista Pharmaceuticals (KALV) United States $0.669B 0.00
AleAnna (ANNA) United States $0.587B 0.00
Relay Therapeutics (RLAY) United States $0.573B 0.00
Verve Therapeutics (VERV) United States $0.570B 0.00
Regulus Therapeutics (RGLS) United States $0.564B 0.00
USANA Health Sciences (USNA) United States $0.556B 12.09
Bioventus (BVS) United States $0.551B 13.98
Theravance Biopharma (TBPH) United States $0.531B 0.00
Altimmune (ALT) United States $0.530B 0.00
Zevra Therapeutics (ZVRA) United States $0.513B 0.00
Tourmaline Bio (TRML) United States $0.490B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.483B 0.00
Oruka Therapeutics (ORKA) United States $0.472B 0.00
Siga Technologies (SIGA) United States $0.453B 9.46
Organogenesis (ORGO) United States $0.412B 0.00
Savara (SVRA) United States $0.380B 0.00
Aquestive Therapeutics (AQST) United States $0.339B 0.00
Heron Therapeutics (HRTX) United States $0.314B 0.00
Liminatus Pharma (LIMN) United States $0.289B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
ProKidney (PROK) United States $0.274B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.10
Esperion Therapeutics (ESPR) United States $0.240B 0.00
Nanobiotix S.A (NBTX) France $0.239B 0.00
MediWound (MDWD) Israel $0.223B 0.00
Profound Medical (PROF) Canada $0.204B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
Larimar Therapeutics (LRMR) United States $0.198B 0.00
OmniAb (OABI) United States $0.198B 0.00
Aldeyra Therapeutics (ALDX) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.170B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.170B 0.00
Journey Medical (DERM) United States $0.161B 0.00
Avita Medical (RCEL) United States $0.160B 0.00
Lexeo Therapeutics (LXEO) United States $0.150B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Korro Bio (KRRO) United States $0.140B 0.00
Lyell Immunopharma (LYEL) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Achieve Life Sciences (ACHV) Canada $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.119B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.117B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
VAXART, INC (VXRT) United States $0.115B 0.00
Fractyl Health (GUTS) United States $0.111B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Wellgistics Health (WGRX) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Inotiv (NOTV) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.087B 14.25
Cumberland Pharmaceuticals (CPIX) United States $0.085B 63.00
Nutriband (NTRB) United States $0.085B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Jupiter Neurosciences (JUNS) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Prelude Therapeutics (PRLD) United States $0.062B 0.00
NRx Pharmaceuticals (NRXP) United States $0.060B 0.00
PMV Pharmaceuticals (PMVP) United States $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Context Therapeutics (CNTX) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Avalo Therapeutics (AVTX) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
FibroGen (FGEN) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.028B 0.00
Relmada Therapeutics (RLMD) United States $0.025B 0.00
Carisma Therapeutics (CARM) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.11
Ainos (AIMD) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
SHINECO (SISI) China $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00